Abstract Details
|
Emer McGrath, MB, BCh, PhD
PRESENTER |
Dr. McGrath has nothing to disclose. |
| Jayandra Himali | Jayandra Himali has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Alexa Beiser | Alexa Beiser has nothing to disclose. |
| No disclosure on file | |
| Claudia L. Satizabal, PhD (UT Health San Antonio) | The institution of Dr. Satizabal has received research support from NIH and TARCC. |
| Matthew Pase, PhD (Monash University) | Dr. Pase has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheimer's Disease Drug Discovery Foundation. |
| No disclosure on file | |
| Sudha Seshadri, MD, FÂé¶¹´«Ã½Ó³» (Glenn Biggs Institute for Alzheimer'S and Neurodegenerative Diseases) | Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association. |